Adrian Gottschalk insider trades
Open-market stock purchases and sales by Adrian Gottschalk, Chief Executive Officer at Foghorn Therapeutics Inc, from SEC Form 4 filings since Oct 27, 2020.
Companies traded
- FHTX Foghorn Therapeutics Inc: other filings, last Apr 10, 2026